pathway,nums,percent,pvalue,,
Spliceosome,98,96.08,0,,
DNA replication,33,100,0,,
Ribosome biogenesis in eukaryotes,52,92.86,0,,
Nuclear pore complex,25,83.33,0,,
Mismatch repair,22,100,0,,
Base excision repair,30,90.91,0,,
"Spliceosome, U4/U6.U5 tri-snRNP",18,85.71,0,,
mRNA surveillance pathway,60,89.55,0,,
Homologous recombination,29,93.55,0,,
Polycomb repressive complex,60,95.24,0,,
RNA polymerase,18,81.82,0,,
Ribosome,86,86,0,,
"Ribosome, eukaryotes",63,95.45,0,,
BRCA1-associated genome surveillance complex (BASC),15,100,0,,
RNA degradation,38,82.61,0,,
"Spliceosome, 35S U5-snRNP",22,84.62,0,,
"Spliceosome, U2-snRNP",18,94.74,0,,
Coronavirus disease - COVID-19,99,84.62,0,,
Nucleocytoplasmic transport,79,95.18,0,,
RNA transport,111,96.52,0.0002,,
Cell cycle,128,98.46,0.0002,,
"Spliceosome, U1-snRNP",9,100,0.0005,,
Nucleotide excision repair,36,85.71,0.0012,,
Exon junction complex (EJC),16,100,0.0015,,
Fanconi anemia pathway,28,87.5,0.0023,,
Sm core complex,7,100,0.0031,,
MCM complex,6,100,0.0041,,
Herpes simplex infection,87,92.55,0.0041,,
RF-C complex,5,100,0.0055,,
"RNA polymerase I, eukaryotes",7,100,0.0056,,
FA core complex,6,100,0.0069,,
"RNA polymerase II, eukaryotes",6,100,0.0102,,
Cell cycle - G2/M transition,7,100,0.01,,
"RNA polymerase III, eukaryotes",10,90.91,0.0151,,
DNA damage-induced cell cycle checkpoints,7,100,0.016,,
Glycolysis / Gluconeogenesis,13,41.94,0.016,,
"Inosine monophosphate biosynthesis, PRPP + glutamine => IMP",6,100,0.0205,,
"Exosome, eukaryotes",6,100,0.0261,,
Non-homologous end-joining,6,100,0.0398,,
Folate biosynthesis,5,45.45,0.0498,,
Metabolism of xenobiotics by cytochrome P450,10,38.46,0.0934,,
Basal transcription factors,31,79.49,0.0934,,
Shelterin complex,5,100,0.1019,,
Chemical carcinogenesis - DNA adducts,7,35,0.1164,,
Systemic lupus erythematosus,8,66.67,0.1443,,
Oocyte meiosis,63,80.77,0.1804,,
African trypanosomiasis,8,57.14,0.2083,,
Cytosolic DNA-sensing pathway,27,84.38,0.2238,,
Methionine salvage pathway,4,80,0.2213,,
Viral life cycle - HIV-1,26,76.47,0.2186,,
Drug metabolism - cytochrome P450,8,34.78,0.2373,,
Methionine degradation,4,66.67,0.2515,,
Origin recognition complex,6,100,0.2542,,
Inositol phosphate metabolism,22,47.83,0.269,,
"Glycolysis (Embden-Meyerhof pathway), glucose => pyruvate",11,100,0.2684,,
Progesterone-mediated oocyte maturation,54,80.6,0.269,,
Arginine and proline metabolism,11,40.74,0.2783,,
TREX complex,8,100,0.3046,,
Tyrosine metabolism,17,100,0.3245,,
Purine metabolism,91,94.79,0.3246,,
Phosphatidylinositol signaling system,26,45.61,0.3206,,
Sulfur metabolism,3,33.33,0.3324,,
"Spliceosome, Prp19/CDC5L complex",8,100,0.3361,,
Phenylalanine metabolism,10,100,0.3314,,
One carbon pool by folate,11,84.62,0.3314,,
Antifolate resistance,12,80,0.3275,,
beta-Alanine metabolism,5,26.32,0.335,,
Nicotine addiction,3,60,0.3525,,
Thyroid cancer,11,52.38,0.3816,,
Primary immunodeficiency,5,71.43,0.3779,,
Glycerolipid metabolism,15,60,0.3764,,
Fructose and mannose metabolism,18,100,0.3852,,
Platinum drug resistance,41,70.69,0.3919,,
Chemical carcinogenesis - receptor activation,67,65.69,0.3915,,
Transcriptional misregulation in cancer,87,94.57,0.4355,,
Pyrimidine metabolism,65,91.55,0.4314,,
Notch signaling,3,37.5,0.4396,,
Triacylglycerol biosynthesis,9,100,0.505,,
Nitrogen metabolism,5,83.33,0.5087,,
Chemical carcinogenesis - reactive oxygen species,47,38.52,0.6168,,
NOD-like receptor signaling pathway,51,53.68,0.6944,,
Retinol metabolism,6,60,0.7038,,
"Gluconeogenesis, oxaloacetate => fructose-6P",8,100,0.704,,
Bladder cancer,16,66.67,0.7149,,
Holo-TFIIH complex,10,100,0.7162,,
Glutathione metabolism,28,70,0.7425,,
Prion diseases,10,47.62,0.7456,,
BER complex,8,100,0.7453,,
Citrate cycle (TCA cycle),21,100,0.7615,,
Cysteine and methionine metabolism,23,82.14,0.7857,,
RIG-I-like receptor signaling pathway,20,64.52,0.8064,,
"Alanine, aspartate and glutamate metabolism",15,65.22,0.8483,,
"C1-unit interconversion, eukaryotes",6,100,0.8628,,
Endometrial cancer,22,64.71,0.9109,,
"O-glycan biosynthesis, mucin type core",4,40,0.9197,,
Drug metabolism - other enzymes,31,77.5,0.9145,,
Selenocompound metabolism,11,100,0.9095,,
Activin signaling,6,100,0.9089,,
Mucin type O-glycan biosynthesis,4,33.33,0.9009,,
Staphylococcus aureus infection,11,78.57,0.9266,,
Carbon metabolism,37,54.41,0.9197,,
Aminoacyl-tRNA biosynthesis,22,75.86,0.9215,,
"Aminoacyl-tRNA biosynthesis, eukaryotes",18,72,0.9173,,
Breast cancer,56,77.78,0.9128,,
Signaling pathways regulating pluripotency of stem cells,59,74.68,0.9347,,
Legionellosis,17,70.83,0.9293,,
IL-17 signaling pathway,25,62.5,0.9539,,
Huntington's disease,65,60.19,0.9531,,
Survival motor neuron (SMN) complex,8,100,0.9686,,
Neuroactive ligand-receptor interaction,20,41.67,0.9753,,
APC/C complex,8,66.67,0.9699,,
Biosynthesis of amino acids,25,59.52,0.9858,,
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,6,100,0.9866,,
Hepatocellular carcinoma,82,81.19,1,,
Notch signaling pathway,21,63.64,1,,
Thyroid hormone signaling pathway,56,76.71,1,,
Prostate cancer,54,90,0.9949,,
THC complex,5,100,0.9983,,
Gastric cancer,54,75,1,,
Central carbon metabolism in cancer,20,47.62,0.9945,,
Longevity regulating pathway - multiple species,14,35.9,1,,
"Citrate cycle (TCA cycle, Krebs cycle)",17,100,1,,
Lipoic acid metabolism,11,100,1,,
Colorectal cancer,36,64.29,0.9946,,
ECM-receptor interaction,11,25.58,0.9936,,
Fat digestion and absorption,12,100,1,,
NF-kappa B signaling pathway,29,54.72,0.9933,,
Proximal tubule bicarbonate reclamation,7,50,0.9857,,
Acute myeloid leukemia,29,72.5,0.9782,,
Amyotrophic lateral sclerosis (ALS),18,58.06,0.9767,,
Basal cell carcinoma,16,66.67,0.9794,,
2-Oxocarboxylic acid metabolism,20,100,0.9724,,
Hippo signaling pathway -multiple species,5,29.41,0.9698,,
Arginine biosynthesis,9,100,0.9646,,
Amyotrophic lateral sclerosis,147,76.17,0.9581,,
Hippo signaling pathway - multiple species,5,29.41,0.952,,
Cell cycle - G1/S transition,11,91.67,0.9469,,
Hippo signaling,5,41.67,0.9608,,
Glucagon signaling pathway,36,70.59,0.9567,,
Mineral absorption,6,42.86,0.9583,,
Peroxisome,10,25,0.9561,,
Histidine metabolism,11,100,0.9505,,
Cytochrome bc1 complex,7,100,0.944,,
BMP signaling,5,45.45,0.9453,,
Antigen processing and presentation,16,66.67,0.9388,,
ErbB signaling pathway,22,43.14,0.9795,,
Nucleotide metabolism,40,85.11,0.9739,,
Pentose phosphate pathway,13,100,0.97,,
Ubiquitin mediated proteolysis,69,78.41,0.9728,,
Cell adhesion molecules,27,61.36,0.9757,,
Mitophagy - animal,16,37.21,0.9731,,
Cell adhesion molecules (CAMs),26,63.41,0.9747,,
"Glycine, serine and threonine metabolism",15,75,0.9706,,
Fluid shear stress and atherosclerosis,38,45.78,0.967,,
eIF4F complex,7,100,0.9645,,
"Citrate cycle, second carbon oxidation, 2-oxoglutarate => oxaloacetate",11,100,0.9604,,
Chronic myeloid leukemia,45,83.33,0.966,,
ATP-dependent chromatin remodeling,64,92.75,0.9605,,
N-glycan precursor biosynthesis,4,57.14,0.9594,,
Glyoxylate and dicarboxylate metabolism,11,55,0.9685,,
Leishmaniasis,17,53.12,0.9696,,
Lipid and atherosclerosis,69,69.7,0.9945,,
Biosynthesis of nucleotide sugars,7,31.82,0.9904,,
Th17 cell differentiation,33,67.35,0.9986,,
"Malonate semialdehyde pathway, propanoyl-CoA => acetyl-CoA",1,20,NA,,
